Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs

This publication has 29 references indexed in Scilit:

• Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review
  AIDS and Behavior, 2013
• Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
  Clinical Infectious Diseases, 2013
• Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland
  International Journal of Drug Policy, 2012
• The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
  Addiction, 2011
• A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs
  The Journal of Infectious Diseases, 2011
• Trends in Human Immunodeficiency Virus Incidence and Risk Behavior Among Injection Drug Users in Montreal, Canada: A 16-Year Longitudinal Study
  American Journal of Epidemiology, 2011
• Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews
  Addiction, 2010
• Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8 ⁺ Memory T Cells
  Journal of Virology, 2008
• Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
  Addiction, 2007
• Martingale-based residuals for survival models
  Biometrika, 1990